With the clinical hold on the tab-cel application lifted, phase 2 and 3 trials of the T-cell immunotherapy in patients with ...

The Min protein system prevents abnormal cell division in bacteria, but is poorly understood. Researchers have uncovered how engineered e.coli bacteria control protein levels for maximum efficiency.